PET/CT Scans Show Promise for Non-Invasive Diagnosis of Aggressive Head and Neck Cancers
An international study involving Lukas Kenner, guest professor at Umeå University, has revealed that PET/CT scans can capture the molecular activity of aggressive HPV-negative head and neck squamous cell carcinomas. This breakthrough offers potential for non-invasive diagnosis and treatment monitoring.
The scans can detect biological activity in tumors without the need for a biopsy.
Key Findings
- Tumor Biology Detection: Tumors driven by activation of the Hedgehog signaling pathway show distinct PET/CT patterns. These tumors accumulate more tracer, indicating higher biological activity and a poorer prognosis.
- Laboratory Validation: When researchers blocked the Hedgehog pathway in experiments, tumor growth was reduced and PET/CT signals changed—mirroring the patterns seen in patient imaging.
- Non-Invasive Monitoring: The study suggests that PET/CT could replace invasive biopsies for monitoring how tumors respond to biological treatments.
Methods
The research team analyzed tumor samples alongside clinical PET/CT imaging from patients with HPV-negative head and neck cancer. They combined molecular multi-omics with quantitative imaging analysis to link tumor biology to radiological features.
Future Implications
While the approach may contribute to AI-supported cancer diagnostics and individualized therapy decisions, prospective clinical studies are needed before it can be used routinely.